Introduction
============

To achieve a successful tumor imaging, molecular imagers should design biocompatible probes which can not only overcome the delivery barriers to tumors but also amplify their signals at the targeting sites [@B1], [@B2]. Small-molecule-based (SMB) probes can easily translocate cellular membranes via either passive diffusion or electrostatic interaction if they are designed with care [@B3]-[@B5]. However, it is necessary for SMB probes to concentrate at the targets to amplify the signal to noise (S/N) ratio thus to achieve desired contrast for imaging [@B6]-[@B10]. These amplification strategies, which are complicated and difficult to design, include pretargeting [@B11], [@B12], avidin-biotin conjugation [@B13]-[@B15], enzymatic reactions [@B16]-[@B18], fluorescence resonance energy transfer (FRET) [@B19], [@B20], increasing *R*~1~ or *R*~2~ at magnetic resonance imaging (MRI) [@B21]-[@B26], and so on. Nanoprobes have emerged as a promising tool for tumor imaging due to their ability of loading as many small molecular probes as needed to yield enough contrast without signal amplification, if they are precisely delivered to the tumor sites [@B27]-[@B36]. Nevertheless, besides the difficulty of their fabrication reproducibility, it is harder for nanoprobes to translocate cell membranes than SMB probes do [@B37]-[@B39]. Thus, naturally, we thought of utilizing a "smart", controlled intracellular self-assembly system, which starts with SMB probe to translocate cell membrane and ends up with nanoscale probes at the targets, to amplify signals. The "smart" system we employed herein was proposed by Rao and co-workers and has shown promising applications for self-assembling nanostructures, imaging enzyme activities in cells, designing "smart" probes for tumor MRI, enhancing cell uptake of radioactive probes, etc [@B40]-[@B45].

Our design is illustrated in Scheme [1](#SC1){ref-type="fig"}. Briefly, the SMB probe, Acetyl-Arg-Val-Arg-Arg-Cys(StBu)-Lys(^18^F-FB)-CBT (**1**), was designed to have these components as following: (1) a RVRR peptide sequence for cell-membrane-translocation and furin (a protease overexpressed in cancer) cleavage; (2) a disulfided Cys for supplying the 1,2-aminothiol group to condense with the cyano group on the 2-cyanobenzothiazole (CBT) motif; (3) a Lys whose side chain is covalently conjugated with 4-^18^F-fluorobenzoate (^18^F-FB) for positron emission tomography (PET) imaging. After entering cancer cells, the disulfide bond of the Cys motif of **1** is reduced by the intracellular glutathione (GSH) and subsequently its RVRR motif is cleaved by furin, resulting in the active intermediate **1-Core**. Two **1-Core**s quickly condense to yield the amphiphilic oligomers (e.g., dimer of **1-Core**, **1-Dimer)**which self-assemble into nanoparticles (i.e., **1-NPs**) via π-π stacking among each other. As-formed **1-NPs** could concentrate the radioactivity inside tumor cells, rendering enhanced PET imaging of tumors. Moreover, the big size and the hydrophobic nature of **1-NPs** would prevent themselves from being pumped out by the cells, resulting in longer retention time in cells or longer circulation time *in vivo*, which is also good for tumor imaging. However, before approaching to furin at Golgi bodies, the cyano group of the radioactive probe **1** at very low chemical concentration (7.1 pmol kg^-1^ for PET imaging in this work) would condense with intracellular Cys, causing its self-condensation and assembly of **1-NPs** infeasible. To resolve this, we have demonstrated that co-incubation of the radioactive probe (e.g., **1** herein) with its cold analog (e.g., **1-Cold** herein Figure [1](#F1){ref-type="fig"}) above 25 µM would conquer intracellular Cys and warrant the self-assembly of the radioactive nanoparticles inside cells [@B44]. In this paper, we designed **1-Cold** for the co-injection with **1** into nude mice xenografted with MDA-MB-468 breast tumors that overexpress furin. We found that mice co-injected with **1** and **1-Cold** show obviously higher uptake of radioactivity in tissues than those only injected with **1**. During the 360 min microPET imaging of mice post injection, tumor uptake ratio between mice of these two groups gradually increased, reaching its maximum of 8.2 folds at 240 min.

Materials and Methods
=====================

Materials
---------

All the starting materials were obtained from Adamas or Sangon Biotech. Commercially available reagents were used without further purification, unless noted otherwise. All chemicals were reagent grade or better. Furin was purchased from Biolabs (2,000 U mL^-1^, one unit (U) corresponds to the amount of furin that releases 1 pmol of methylcoumarinamide (MCA) from the fluorogenic peptide Boc-RVRR-MCA (Bachem) in one minute at 30 °C). ^1^HNMR spectra were obtained on a 300 MHz Bruker AV 300. MALDI-TOF/TOF and ESI mass spectra were obtained on a time-of-flight Ultrflex II mass spectrometer (Bruker Daltonics) and on a Finnigan LCQ Advantage ion trap mass spectrometer (ThermoFisher Corporation) equipped with a standard ESI source, respectively. High performance liquid chromatography (HPLC) analyses were performed on an Agilent 1200 HPLC system equipped with a G1322A pump and in-line diode array UV detector and a YMC-Pack ODS-AM column with CH~3~CN (0.1% of TFA) and water (0.1% of TFA) as the eluent. Semipreparative HPLC for radiosyntheses were performed on a Waters preparative chromatography packed with waters 2998 photodiode array detector and Bioscan flow-count equipped with C18 column (5 µm, 10 mm × 250 mm, Wuxi Chrom-matrix Bio-Technology Co., Ltd. China) with CH~3~CN (0.1% of TFA) and water (0.1% of TFA) as the eluent. Dynamic light scattering (DLS) was measured on a Zeta Sizer Nano Series (Malvern Instruments). Transmission electron micrograph (TEM) images in Figure [2](#F2){ref-type="fig"} were obtained on a JEOL 2100 electron microscope, operating at 200 kV. The cryo-dried samples were prepared as following: a copper grid coated with carbon was dipped into the suspension solvent and placed into a vial, which was plunged into liquid nitrogen until no bubbles were apparent. Then water was removed from the frozen specimen by a freeze-drier. TEM images in Figure [3](#F3){ref-type="fig"} were obtained on a FEI Techni 12 electron microscope, operating at 120 kV. UV-vis absorbance spectra were recorded on a lambda 25 UV-visible spectrophotometer (PerkinElmer, America) at room temperature. Fluorescence spectra were recorded on a F-4600 fluorescence spectrophotometer (Hitachi High-Technologies Corporation, Japan) with excitation wavelength set to 320 nm. \[^18^F\]-fluoride was prepared by medical cyclotron (Sumitomo HM-7, Japan). Micro-PET imaging was performed on an Inveon scanner (Siemens, Germany). The radionuclide activity meter was curiementor-3 (PTW, Germany).

Cell Culture
------------

MDA-MB-468 human breast adenocarcinoma epithelial cells were cultured in Dulbecco\'s modified eagle medium (GIBCO) supplemented with 10% fetal bovine serum (FBS, GIBCO). The cells were expanded in tissue culture dishes and kept in a humidified atmosphere of 5% CO~2~ at 37 °C. The medium was changed every other day.

Western Blot
------------

MDA-MB-468 cells were cultured on a 10-cm dish, then washed with cold PBS for three times and harvested in 1.5 mL eppendorf tubes, followed by centrifugation at 3,000 rpm and 4 °C for 10 min. The supernatants were removed and the cell samples were treated with radioimmunoprecipitation assay (RIPA) lysis buffer containing 4% protease inhibitor (Roche). Cells in the mixture were broken by Sonifier cell disruptor (200 W, 6 s) and lysed for 3 min on ice. Cell extracts were clarified by centrifugation at 12,000 rpm and 4 °C for 15 min, and then mixed with SDS sample buffer for denaturation at 100 °C for 5 min. Proteins were separated by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) and transferred to Immun-Blot with NC (nitrocellulose) membrane. Western blotting was carried out using anti-furin (1:1000, Sigma Aldrich) or β-actin (1:5000, Cell Signaling Technology) at 4 °C overnight and horse radish peroxidase (HRP)-conjugated secondary antibodies at room temperature for 1 h. All antibodies were used in 5% skim milk (BD Bioscience).

Cell Imaging
------------

MDA-MB-468 human breast adenocarcinoma epithelial cells (3 × 10^6^) were incubated with 100 µM **1-Cold** at 37 °C for 0.5 h. The cells were washed with PBS for three times, imaged under an Olympus IX71 Inverted optical fluorescence microscopy, and presented in Figure [3](#F3){ref-type="fig"}.

Furin Immunofluorescence Staining
---------------------------------

MDA-MB-468 cells were plated on glass coverslips in 24-well plates at 50% cell density the next day. After the medium was removed and the cells were washed for 3 times with PBS, cells were incubated with **1-Cold** at 100 μM for 1 h, washed for three times with PBS, fixed with 4% paraformaldehyde at room temperature for 30 min. Subsequently, fixed cells were washed for 3 times with PBS and permeabilized with 1% Triton X-100/PBS for 20 min, followed by blocking with 10% goat serum solution in PBS for 30 min at room temperature. After blocking, cells were incubated with primary antibody (1:200, antifurin rabbit polyclonal antibody (Sigma)) for 1 h at 37 °C. After washing for three times with PBS, cells were incubated with secondary antibody (1: 200, goat polyclonal antirabbit IgG rhodamine conjugate) for 1 h at 37 °C. After being washed with PBS for three times and distilled water once, the final samples were mounted on a glass slide. Images were acquired using a Leica TCS SP5 microscope equipped with a 63× objective.

Cell Uptake
-----------

MDA-MB-468 cells were seeded in 6-well plates for 6 h at a number of 600,000 for each well. After that, the medium was replaced with fresh medium containing 1 µCi of **1** for each well. At 5, 10, 20, 30, 60, and 90 min, cells and medium were harvested for counting the radioactivity by a γ-counter.

Cellular Efflux Titration
-------------------------

MDA-MB-468 cells in 6-well plates at a number of 1 million for each well were incubated with 4 μCi of **1** and **1-Cold** at 0, 5, 25, 50 μM at 37 °C, respectively. After 1 hour incubation, the medium was replaced with fresh medium and the efflux starts as time 0 min. At 5, 10, 20, 30, 60, 90 and 120 min, the medium was changed and the radioactivity of the old medium was counted. At 120 min, the cells were also harvested for counting the radioactivity and calculating the total radioactivity at time 0.

Electron Microscopic Imaging of Cells
-------------------------------------

MDA-MB-468 cells were incubated with **1-Cold** at 100 µM for 8 h, washed for three times with phosphate-buffered saline (PBS), fixed with 2.5% glutaraldehyde at room temperature for 30 min. The cells were then detached from culture dishes, centrifuged (300 rpm, 15 min) and washed with PBS for further three times, and then stained with 1% OsO~4~ in double-distilled water for 1.5 h. Then the cells were dehydrated in ethanol and embedded in Epon. Thin sections (80 nm) were cut and mounted on copper grids, stained with saturated solution of uranyl acetate and lead citrate for electron microscope observation.

MTT Assay
---------

The cytotoxicity was measured using the 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) assay with MDA-MB-468 cells. Cells growing in log phase were seeded into 96-well cell culture plate at 3 × 10^3^/well. The cells were incubated for 12 h at 37 ^o^C under 5% CO~2~. The solutions of **1-Cold** (100 µL/well) at concentrations of 25, 50 or 100 µM in medium were added to the wells, respectively. The cells were incubated for 3, 6 and 12 h at 37 °C under 5% CO~2~. A solution of 5 mg/mL MTT dissolved in phosphate buffered saline (PBS) (pH 7.4) (10 µL /well) was added to each well of the 96-well plate. A solution of 10% SDS/phosphate buffered saline (PBS) (pH 7.4) (100 µL/well) was added to dissolve the formazan after an additional 4 hour incubation. The data were obtained using an ELISA reader (VARIOSKAN FLASH) to detect its absorption at 570/680 nm. The following formula was used to calculate the viability of cell growth: Viability (%) = (mean of Absorbance value of treatment group/mean of Absorbance value of control) × 100.

Radiolabeling of 2
------------------

^18^F-SFB (20 µL, 5 mCi) was added into the 150 µL solution of **2** (100 µg, 90 nmol) dissolved in phosphate buffered saline (PBS) at pH 7.2, stirred at 50 °C for 0.5 h. Then the reaction mixture was injected into the radio-HPLC for purification and analysis. the HPLC peak at 15.9 min on the raio-HPLC trace, which has a same retention time to that of **1-Cold**, was collected and dried at 100 °C by N~2~ to remove the acetonitrile as **1** with 50% radiochemical yield (RCY) (decay-corrected to the end of synthesis).

In Vivo MicroPET Scans
----------------------

Female BALB/c nude mice of 4-8 weeks old were bought from Shanghai Silaike Experimental Animals Corporation. All animals received care in compliance with the guidelines outlined in the Guide for the Care and Use of Laboratory Animals. The procedures were approved by the Jiangsu Institute of Nuclear Medicine Animal Care and Use Committee. MDA-MB-468 tumor lesions were established by subcutaneous foreleg injection of 4 × 10^7^ tumor cells in 100 µL PBS for each mouse. Visible tumors were normally observed 4 - 6 weeks after injection. The tumor-xenografted mice immobilized by isoflurane anaesthesia were then subjected randomly into two groups for tail vein injections of **1** or co-injections of **1** with**1-Cold** (injection dose for each mouse: **1**at 85 µCi and **1-Cold** at 20 µmol/kg). Ten-minute static PET images were acquired at 10 min, 30 min, 1 h, 2 h, 4 h and 6 h post-injection. The image reconstruction was done by the 3-dimensional ordered subsets expectation maximum (3D OSEM) algorithm without attenuation or scatter correction. Regions of interest (ROIs) over the tumor and major organs were drawn on decay-corrected whole-body coronal images using vendor software (ASI Pro 6.7.1.1) for each microPET scan. The radioactivity concentration (accumulation) within a tumor or an organ was obtained from mean pixel values within the multiple ROI volume, which had been converted to MBq/mL/min by using a conversion factor. The conversion to MBq/g/min assumed a tissue density of 1 g/mL. Imaging ROI-derived % ID/g was calculated by dividing the ROIs by the administered activity.

Results and Discussion
======================

Syntheses and Rationale of the Design
-------------------------------------

We began the study with the syntheses of the precursor **2** for **1**, and **1-Cold** for the demonstration of furin-controlled condensation and self-assembly of nanoparticles *in vitro* and *in vivo* (Figure [1](#F1){ref-type="fig"} and [Supplementary Material](#SM1){ref-type="supplementary-material"}). The syntheses are facile and straightforward. Briefly, peptide sequence Ac-Arg-Val-Arg-Arg-Cys(StBu)-Lys-OH (**A**) with protection groups was synthesized with solid phase peptide synthesis (SPPS), then coupled with CBT, purified with HPLC to yield **B** (Scheme S1). Deprotection of **B** yields **2** after HPLC purification. N-succinimidyl-4-fluorobenzoate (SFB) was synthesized according to the literature [@B46]. Coupling of **2** with SFB at pH 8.5 and room temperature for 6 h yields **1-Cold** after HPLC purification with good yield (70%). ^18^F-SFB was also synthesized according to the literature [@B47], purified with a C18 Sep-Pak Cartridge. Labeling of **2** with^18^F-SFB at pH 7.2 and 50 °C for 0.5 h yields **1**after HPLC purification.

Furin-controlled Condensation of 1-Cold and Self-assembly of 1-Cold-NPs, and Nanocharacterizations
--------------------------------------------------------------------------------------------------

To validate furin-controlled condensation and self-assembly, we used **1-Cold** for the *in vitro* study. As shown in Figure [2](#F2){ref-type="fig"}a, after 4 h incubation of **1-Cold** at 100 µM and 37 °C with 1 nmol/U of furin, we directly injected the incubation mixture into a HPLC system and collected the peaks for matrix-assisted laser desorption/ionization (MALDI) mass spectroscopic analysis. Peak on HPLC trace at retention time of 38.9 min was identified as the condensation product of **1-Cold** after furin cleavage (i.e., **1-Cold-Dimer**, Figure [2](#F2){ref-type="fig"}a and [Supplementary Material](#SM1){ref-type="supplementary-material"}: Figure S9). Time course HPLC analysis of furin cleavage indicated that, at this condition, furin-controlled condensation of **1-Cold** was accomplished in 2 h and the products (i.e., **1-Cold-Dimer**) are stable until 8 h ([Supplementary Material](#SM1){ref-type="supplementary-material"}: Figure S9). This suggests that **1-Cold** has an average speed of furin cleavage (8.3 pmol/U per minute) at 37 °C, much faster than that of commercial substrate Boc-RVRR-AMC (Bachem, 1 pmol/U per min) at 30 °C. Using HPLC and fluorescence spectroscopic analyses, we calculated the enzymatic Michaelis-Menten constants (*K*~M~) of furin towards **1-Cold** and Boc-RVRR-AMC to be 242 µM and 99 µM, respectively ([Supplementary Material](#SM1){ref-type="supplementary-material"}: Figure S10). This indicated that the binding affinity of**1-Cold** to furin was 2.4-fold-lower than that of Boc-RVRR-AMC. However, the calculated *K*~cat~ and *K*~cat~/*K*~M~ values of furin towards **1-Cold** were 35 times and 15 times of those of Boc-RVRR-AMC ([Supplementary Material](#SM1){ref-type="supplementary-material"}: Figure S10), respectively, echoing that furin cleaves **1-Cold** faster than Boc-RVRR-AMC. UV-vis spectra at 500-700 nm of the incubation mixture at 4 h showed an obvious increase of absorption compared with that before incubation, suggesting the aggregation of nanoparticles ([Supplementary Material](#SM1){ref-type="supplementary-material"}: Figure S11). Directly taking the above dispersion for scanning electron microscope (SEM) and transmission electron microscope (TEM) observation, we found that the nanoparticles have an average diameter of 182 ± 70 nm under TEM (Figure [2](#F2){ref-type="fig"}c) and an average diameter of 207 ± 99 nm under SEM (Figure [2](#F2){ref-type="fig"}b).

Cell Permeability of 1 and 1-Cold, Intracellular Self-Assembly of 1-Cold-NPs, and Biocompatibility Study of 1-Cold
------------------------------------------------------------------------------------------------------------------

After the validation of furin-controlled condensation and self-assembly, we studied the cell permeability of **1** and **1-Cold**, as well as the biocompatibility of **1-Cold**. Cell permeability study of **1** was conducted by incubating the probe with MDA-MB-468 cells and quantitating its cellular uptake by counting the radioactivity with a γ-counter. Cell permeability of **1-Cold** was evaluated by directly taking the fluorescence images of the cells incubated with the probe, since **1-Cold** has a strong fluorescence emission at 450 nm after furin-controlled condensation in cells. Before applying **1** or **1-Cold** for the cellular experiments, we tested the expression level of furin in human breast cancer cell line MDA-MB-468 with western blot. Human colon carcinoma LoVo cells were chosen as control cell lines because they are reported to be furin-deficient [@B48]. The results showed that MDA-MB-468 cells have a positive signal for furin (31.2% of β-actin) while very weak signal of furin (10.4% of β-actin) was detected in LoVo cells ([Supplementary Material](#SM1){ref-type="supplementary-material"}: Figure S12). As shown in Figure [3](#F3){ref-type="fig"}b, cellular uptake of **1** rapidly approached its plateaus at 30 min (20.4% of total radioactivity) and reached its maximum of 22.2% at 60 min, suggesting that **1** could be quickly and efficiently uptaken by the MDA-MB-468 cells. For the MDA-MB-468 cells incubated with 100 µM **1-Cold** at 37 °C for 0.5 h, strong fluorescence emissions inside the cells were clearly observed, suggesting the good cell permeability of **1-Cold**. To determine the localization of the condensation products of **1-Cold**, we incubated 100 µM **1-Cold** with the cells at 37 °C for 1 h and then immunofluorescence staining of furin in the cells was conducted using rhodamine-labelled secondary antibody. An overlay of the fluorescence image of the condensation products of **1-Cold** with that of furin staining clearly shows that the condensation products of **1-Cold** are actually at or near the localizations of furin (i.e., Golgi bodies) ([Supplementary Material](#SM1){ref-type="supplementary-material"}: Figure S13). To directly validate the formation of **1-Cold-NPs** in MDA-MB-468 cells, we incubated the cells with 100 µM **1-Cold** for 8 h and sliced the cells for electron microscope (EM) observation. As shown in Figure [3](#F3){ref-type="fig"}c-d, clearly we found that the intracellular nanoparticles of **1-Cold** (i.e., **1-Cold-NPs**) were near/at Golgi bodies where the furin enzyme was activated. After that, we studied the biocompatibility of **1-Cold**. 3-(4,5-dimethylthiazol-2-yl) 2,5-diphenyltetrazolium bromide (MTT) assay indicated, after being incubated with **1-Cold** at 25 µM, 50 µM, or 100 µM for 3 h, 110%, 103%, or 87% of the MDA-MB-468 cells survived respectively ([Supplementary Material](#SM1){ref-type="supplementary-material"}: Figure S14). When the cells were incubated with 25 µM, 50 µM, or 100 µM **1-Cold** for 12 h, 98%, 105% or 68% of the cells survived respectively, suggesting **1-Cold** is nontoxic to the cells until 12 h.

Radiolabeling
-------------

To ensure a successful radio-synthesis of **1**, we used a radio**-**HPLC equipped with a UV-vis detector and a γ-counter to monitor the reaction. In detail, ^18^F-SFB was synthesized according to the literature and purified with a C18 Sep-Pak cartridge. Compared with SFB which has a retention time of 14.1 min on the HPLC chromatograph, purified ^18^F-SFB has a retention time of 14.2 min and radiochemical purity more than 90% (Figure [4](#F4){ref-type="fig"}). After that, ^18^F-SFB (20 µL, 5 mCi) was added into the solution of **2** (100 µg, 90 nmol) dissolved in 150 µL phosphate buffered saline (PBS) at pH 7.2, heated at 50 °C for 0.5 h. Then the reaction mixture was injected into the radio-HPLC for purification and analysis. As shown in Figure [4](#F4){ref-type="fig"}, the flatheaded HPLC peak at 15.9 min on the radio-HPLC trace, which has a same retention time to that of **1-Cold**, was collected and purified as **1** with 50% radiochemical yield (RCY) (decay-corrected to the end of synthesis, EOS) and specific radioactivity of 0.6 ± 0.4 Ci µmol^-1^ (EOS). The amount of unreacted ^18^F-SFB in the mixture, which has a retention time of 14.4 min, was very tiny. Stability study indicated that **1** was stable in fetal bovine serum at 37 °C up to 5 h (97.7%) ([Supplementary Material](#SM1){ref-type="supplementary-material"}: Figure S15).

MicroPET Imaging of MDA-MB-468 Tumor Xenografts in Mice
-------------------------------------------------------

After validating overexpression of furin in MDA-MB-468 breast cancer cells by western blotting, our next plan was to use MDA-MB-468 tumor xenografts to demonstrate the furin-controlled intracellular self-assembly of **1-NPs***in vivo* for an enhanced microPET imaging of tumors in mice. As aforementioned, to ensure the feasibility of intracellular self-assembly of **1** into **1-NPs**, co-injection of **1-Cold** with **1** into mice to conquer intracellular Cys is a must. To characterize the concentration effect of **1-Cold** on the self-assembly of **1-NPs**, we did cellular efflux titration on MDA-MB-468 cells pre-incubated with 4 μCi of **1** and **1-Cold** at 0, 5, 25, or 50 μM and 37 °C, respectively. The results indicated that 120 min after cell efflux, cells incubated with **1** alone have 13.1 ± 1.2% of initial radioactivity retained while those cells co-incubated with 5, 25, or 50 μM **1-Cold** have 20.3 ± 4.2%, 28.5 ± 1.4%, or 32.1 ± 0.9% of initial radioactivity retained, respectively ([Supplementary Material](#SM1){ref-type="supplementary-material"}: Figure S16). Therefore, in this study, MDA-MB-468 tumor-bearing nude mice were each co-injected with 85 µCi of **1** and 20 µmol/kg **1-Cold** via tail vein for microPET scans. Those tumor-bearing nude mice only injected with the same dosage of **1** were studied in parallel. Before microPET imaging, we conducted pharmacokinetic study of **1** in mice after intravenous (i.v.) administration at about 3.0 mCi/kg. The profiles of mean plasma concentration of **1** vs. time were best fitted to a two-compartment model (R^2^ = 0.957). The blood circulation half-time (*t*~1/2~) was estimated to be 86.1 min (*t*~1/2α~ = 1.4 min, *t*~1/2β~ = 84.7 min). The mean *AUC*~0-*t*~ value was 452.2 min mCi L^-1^, *CL*~tot~ was 0.006 L min^-1^ kg^-1^, *V*~d~ was 1.042 L kg^-1^, and *C*~max~ was 7.471 mCi L^-1^, respectively ([Supplementary Material](#SM1){ref-type="supplementary-material"}: Figure S17). These data indicate that clearance of **1** in mouse is relatively slow. From the preliminary results of radiolabeling and pharmacokinetic study, we could calculate that the co-injection dose of **1-Cold** (i.e., 20 µmol/kg) could result in *C*~max~ of 49.8 µM of **1-Cold** in blood, which is obviously higher than the concentration for self-assembling **1-NPs** (i.e., 25 µM). The microPET imaging results are shown in Figure [5](#F5){ref-type="fig"}a. Coronal microPET imaging of mice showed that MDA-MB-468 tumors in the mice co-injected with **1** and **1-Cold** were clearly visualized with good tumor-to-background contrast from 30 to 360 min (bottom panels of Figure [5](#F5){ref-type="fig"}a). Interestingly, tumors in those mice that only injected with **1** also could be visualized at 30 min and 60 min post injection but their PET images attenuated very fast after 60 min (top panels of Figure [5](#F5){ref-type="fig"}a). These results suggested that the radioactive probe **1** has a good tumor uptake enough for tumor PET imaging but co-injection of **1** with **1-Cold** results in better uptake and longer attenuation of the radioactivity in tumor. Quantitative analysis of radioactivity values of tumor PET images showed that mice co-injected with **1**and **1-Cold** had tumor uptake of radioactivity significantly higher than that of mice only injected with **1** at all time points studied ([Supplementary Material](#SM1){ref-type="supplementary-material"}: Table S4). At time points of 10, 30, 60, 120, 240, 360 min post injection, mice co-injected with **1** and **1-Cold** had tumor uptake of 2.52 ± 0.95%, 4.08 ± 0.48%, 3.31 ± 1.22%, 2.27 ± 1.86%, 1.55 ± 1.75%, 1.28 ± 1.07% ID/g of **1**, respectively. For mice only injected with **1**, they had tumor uptake of 1.02 ± 0.19%, 1.12 ± 0.08%, 0.52 ± 0.18%, 0.28 ± 0.02%, 0.19 ± 0.03%, and 0.19 ± 0.05% ID/g of **1** at these time points respectively ([Supplementary Material](#SM1){ref-type="supplementary-material"}: Table S4). Quantitative results showed that tumor uptake ratios between these two groups of mice are 2.5 (at 10 min), 3.6 (at 30 min), 6.4 (at 60 min), 7.9 (at 120 min), 8.2 (at 240 min), 6.5 (at 360 min), respectively (Figure [5](#F5){ref-type="fig"}b, and [Supplementary Material](#SM1){ref-type="supplementary-material"}: Table S4). These results indicated that co-injection of **1** with **1-Cold** is obviously better than **1**alone for microPET imaging of MDA-MB-468 tumors, suggesting that **1-Cold** helps the furin-controlled intracellular condensation and self-assembly of **1** into ^18^F-NPs (i.e., **1-NPs**) in tumors.

After validating that co-injection of **1** with **1-Cold** enhances the microPET imaging of MDA-MB-468 tumors in mice, we also investigated the biodistribution of **1** in MDA-MB-468 tumor-xenografted nude mice at 10, 30, 60, 120, 240, or 360 min post injection of **1** with **1-Cold** or **1** alone. As shown in Figure [5](#F5){ref-type="fig"}b, mice co-injected with **1** and **1-Cold** exhibited higher uptake of **1** than those only injected with **1** in all organs at all the time points studied, suggesting the formation of **1-NPs** in the tumors and the NPs were slowly digested, degraded, and secreted into these organs. In detail, all the mice showed high uptake of **1** in liver and heart in 30 minutes and rapid clearance of **1** after 60 min. As for kidney and gall bladder, mice injected with **1** showed relatively rapider clearance of **1** in these organs than those co-injected with **1** and**1-Cold**. Interestingly, the uptake ratios of **1** in gall bladders between mice co-injected with **1** and **1-Cold** and those injected with **1** at the time points studied are similar to those in tumors between these two group of mice ([Supplementary Material](#SM1){ref-type="supplementary-material"}: Table S4). However, the uptake ratios of **1** in kidneys between these two groups continuously increased, reaching 81.9 folds at 240 min post injection ([Supplementary Material](#SM1){ref-type="supplementary-material"}: Table S4). This might hint the formation of radioactive NPs in tumors of mice co-injected with **1** and **1-Cold**, and the NPs were slowly dissembled (or digested) into smaller nanoparticles and secreted from the tumors, trapping in the kidneys since glomerular filtration in the kidney is controlled by similar effective pore sizes, and renal excretion is a strong function of hydrodynamic diameter [@B49]. The biodistribution data, together with the microPET imaging results suggest that it is the furin-controlled self-assembly of **1-NPs** in MDA-MB-468 tumor-bearing mice co-injected with **1** and **1-Cold**that greatly enhance the microPET imaging of the tumors.

Conclusions
===========

In conclusion, taking advantage of a biocompatible condensation reaction and the strategy of co-injection, we have successfully developed a new "smart" radioactive probe (i.e., **1**) which self-assembles into radioactive nanoparticles with its cold analog (i.e., **1-Cold**) in cancer cells for enhanced microPET imaging of tumors in nude mice. The enzyme that we employed herein to control the intracellular condensation and self-assembly of **1** or **1-Cold** is furin, one of the trans-Glogi proteases which is overexpressed in some cancer cells (e.g., breast cancer cell MDA-MB-468). After the validations of furin-controlled self-assembly of **1-Cold-NPs***in vitro* with **1-Cold**, good cell permeability of **1** and **1-Cold**, biocompatibility of **1-Cold**, we conducted the microPET imaging of MDA-MB-468 tumors in mice co-injected with **1** and **1-Cold** and in mice injected with **1** alone. The results indicated that mice co-injected with **1** and **1-Cold** showed higher uptake and longer attenuation of the radioactivity in tumors than those mice only injected with same dosage of **1**. Tumor uptake ratios of **1** between these two groups of mice reached the maximum of 8.2 folds at 240 min post injection. Biodistribution studies indicated that the uptake ratios of **1** in kidneys between these two groups continuously increased and reached 81.9 folds at 240 min post injection, suggesting the formation of radioactive NPs (i.e., **1-NPs**) in MDA-MB-468 tumors of mice co-injected with **1** and **1-Cold**. And the nanoparticles were slowly disassembled (or digested) into smaller nanoparticles and secreted from the tumors, trapping in the kidneys. Encouraged by these exciting results above, we envisioned that our \'\'smart\'\' probe (i.e., **1**), together with the strategy of co-injection, might help researchers trace the biomarkers of interest within a longer time window.
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![Shematic illustration of a furin-controlled condensation of **1** to assemble radioactive nanoparticles in cancer cells. After entering cancer cells, the disulfide bond of probe **1**is reduced by GSH and the RVRR peptide sequence is cleaved by furin to yield the active intermediate **1-Core**. Two **1-Core**s condense to yield amphiphilic dimers which self-assemble into **1-NPs** at or near the locations of furin (i.e., Golgi bodies) in cancer cells.](thnov05p1058g001){#SC1}

![Chemical structures of **1** and**1-Cold** for furin-controlled condensation and self-assembly of nanoparticles, and synthetic route for **1**.](thnov05p1058g002){#F1}

![(a) HPLC trace of the incubation mixture of **1-Cold** at 100 µM after 4 h incubation with 1 nmol/U of furin at 37 °C (bottom), and HPLC trace of **1-Cold** in water (top). (b) SEM images of the nanoparticles in the incubation mixture of **1-Cold** at 100 µM after 4 h incubation with 1 nmol/U of furin at 37 °C. (c) TEM images of the nanoparticles in the incubation mixture of **1-Cold** at 100 µM after 4 h incubation with 1 nmol/U of furin at 37 °C.](thnov05p1058g003){#F2}

![(a) Left: Fluorescence image (DAPI channel) of MDA-MB-468 cells after incubation with 100 µM of**1-Cold**at 37 °C for 0.5 h. Right: overlay of differential interference contrast (DIC) with fluorescence images. Scale bars: 20 µm. (b) Time course of cellular uptake of **1** on MDA-MB-468 cells. 600,000 cells were incubated with 1 µCi of **1**. At each time point, cells were harvested to count the radioactivity using a γ-counter. (c) Electron microscopic image of MDA-MB-468 cells after incubation with 100 μM **1-Cold** for 8 h. (d) High magnification electron microscopic image of the square area in c. Large area of clustered **1-Cold-NPs** were found at/near Golgi bodies. N: nucleus. (e) Electron microscopic image of MDA-MB-468 cells.](thnov05p1058g004){#F3}

![HPLC traces of SFB (black, absorbance at 254 nm), **1-Cold** (red, absorbance at 320 nm), ^18^F-SFB (green, radiochromatograph), **1** (blue, radiochromatograph), and reaction mixture of **1**(cyan, radiochromatograph), respectively.](thnov05p1058g005){#F4}

![(a) Representative whole body coronal microPET images of mice with subcutaneously xenografted MDA-MB-468 tumors at different time points post intravenous injections of 85 µCi**1** (top) or 85 µCi**1** with 20 µmol/kg**1-Cold** (bottom) via tail veins. Tumors are indicated by white arrows. (b) Time-course uptake of **1** in heart, liver, kidney, gall bladder, and MDA-MB-468 tumor derived from PET quantification (%ID/g, n = 4 for each group). Tissue radioactivity is expressed as the percentage of injected dose per gram of tissue (%ID/g). \*: Not detectable.](thnov05p1058g006){#F5}
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